

Lung cancer screening with low-dose chest computed tomography (CT) may reveal more than simply lung cancer. According to new research published in CMAJ (Canadian Medical Association Journal), these CTs can detect coronary artery calcium, a high risk factor for coronary artery disease (CAD), in patients without cardiac symptoms.
“Lung cancer screening, although primarily geared towards reducing deaths from lung cancer, also has an opportunity to help tackle the second most common cause of premature death in middle-aged adults, through the identification and risk stratification of coronary atherosclerosis,” writes Dr. Gary Small, University of Ottawa Heart Institute, Ottawa, Ontario, with coauthors.
Coronary artery calcium was discovered in 83% (1232) of the 1486 people screened for lung cancer between March 2017 and November 2018 as part of the Ontario Health Lung Cancer Screening Pilot for People at High Risk, with high levels in 30% (439). More than half of the patients (52% were men), the average age was 66 years, and 68% (1017) were current smokers.
Because lung cancer is the main cause of cancer deaths in Canada, screening programs across the country have implemented low-dose CT for those at risk of lung cancer. These CTs can also easily detect coronary calcification, which is a sign of coronary artery disease, the leading cause of cardiac death.
The success of this pilot program will depend on how clinicians interpret and manage coronary artery calcium readings. However, clinicians must be mindful that there may be negative consequences, such as inappropriate examination following coincidental detection.
“If appropriate therapeutic responses are instituted, lung CT findings could affect survival from 2 leading causes of death: lung cancer and coronary artery disease,” the authors write.
For more information: Caires, M. C., et al. (2024) Prognostic importance of extensive coronary calcium on lung cancer screening chest computed tomography. CMAJ. doi.org/10.1503/cmaj.231602.
more recommended stories
lncRNAs in Tumor Microenvironment Drive Cancer Progression
The tumor microenvironment (TME) is a.
Lyme Disease Symptoms: Why They Linger After Treatment
Lyme disease symptoms that persist after.
Body Image in Young Women: Cultural Influences Matter
A new international study led by.
Early Alzheimer’s Found Through Blood Biomarkers
A new study published in Molecular.
Label-Free Motion Analysis Detects Cancer Cells
Label-free motion analysis is emerging as.
Harmful Chemicals in Children’s Mattresses
A recent study has brought to.
TMS for Post-Stroke Aphasia Shows Remarkable Gains
A new clinical study led by.
CT Scan Overuse May Cause 1 in 20 New U.S. Cancers
A recent study published in JAMA.
Lactation Metabolism: Brain-Hormone Link Uncovered
Understanding how the body adjusts to.
Quantum Technology in Cancer Surgery: New Probe Aims to Improve Outcomes
A groundbreaking project from the University.
Leave a Comment